These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
28. Trends for and Clinical Factors Associated with Choice of Oral P2Y Jain N; Hunt SL; Cui H; Phadnis MA; Mahnken JD; Shireman TI; Dai J; Mehta JL; Rasu RS Cardiovasc Drugs Ther; 2019 Oct; 33(5):511-521. PubMed ID: 31729588 [TBL] [Abstract][Full Text] [Related]
29. Evaluation of a Real-World In-Hospital Antiplatelet-Switching Strategy Following Coronary Interventions: The SWITCH Study. Soueid AE; Kassas I; Rade J; Kakouros N J Invasive Cardiol; 2021 Apr; 33(4):E263-E268. PubMed ID: 33794478 [TBL] [Abstract][Full Text] [Related]
30. Efficacy and Safety of Ticagrelor in Diabetes Patients Undergoing Percutaneous Coronary Intervention: A Meta-Analysis of Randomized Controlled Trials. Zhang Z; Chen O J Cardiovasc Pharmacol; 2021 May; 77(5):536-543. PubMed ID: 33760801 [TBL] [Abstract][Full Text] [Related]
31. Physician and Hospital Utilization of P2Y12 Inhibitors in ST-Segment-Elevation Myocardial Infarction in the United States: A Study From the National Cardiovascular Data Registry's Research to Practice Initiative. Faridi KF; Garratt KN; Kennedy KF; Maddox TM; Secemsky EA; Butala NM; Yeh RW Circ Cardiovasc Qual Outcomes; 2020 Mar; 13(3):e006275. PubMed ID: 32156164 [TBL] [Abstract][Full Text] [Related]
32. Triple Antithrombotic Therapy With Aspirin, P2Y12 Inhibitor, and Warfarin After Percutaneous Coronary Intervention: An Evaluation of Prasugrel or Ticagrelor Versus Clopidogrel. Verlinden NJ; Coons JC; Iasella CJ; Kane-Gill SL J Cardiovasc Pharmacol Ther; 2017 Nov; 22(6):546-551. PubMed ID: 28279076 [TBL] [Abstract][Full Text] [Related]
33. Comparison of platelet reactivity between prasugrel and ticagrelor in patients with acute coronary syndrome: a meta-analysis. Wen M; Li Y; Qu X; Zhu Y; Tian L; Shen Z; Yang X; Shi X BMC Cardiovasc Disord; 2020 Oct; 20(1):430. PubMed ID: 33004000 [TBL] [Abstract][Full Text] [Related]
34. A Genotype-Guided Strategy for Oral P2Y Claassens DMF; Vos GJA; Bergmeijer TO; Hermanides RS; van 't Hof AWJ; van der Harst P; Barbato E; Morisco C; Tjon Joe Gin RM; Asselbergs FW; Mosterd A; Herrman JR; Dewilde WJM; Janssen PWA; Kelder JC; Postma MJ; de Boer A; Boersma C; Deneer VHM; Ten Berg JM N Engl J Med; 2019 Oct; 381(17):1621-1631. PubMed ID: 31479209 [TBL] [Abstract][Full Text] [Related]
35. Effect of Genotype-Guided Oral P2Y12 Inhibitor Selection After Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. Malik AH; Gupta R; Chakraborty S; Mahajan P; Bandyopadhyay D; Yandrapalli S; Zaid S; Sreenivasan J; Chaturvedi A; Mehta SS; Vyas AV; Patel NC; Combs WG; Ahmad H Cardiovasc Revasc Med; 2022 Aug; 41():115-121. PubMed ID: 35033458 [TBL] [Abstract][Full Text] [Related]
36. Switching to Clopidogrel in Patients With Acute Coronary Syndrome Managed With Percutaneous Coronary Intervention Initially Treated With Prasugrel or Ticagrelor: Systematic Review and Meta-analysis. Hong J; Turgeon RD; Pearson GJ Ann Pharmacother; 2019 Oct; 53(10):997-1004. PubMed ID: 30999764 [No Abstract] [Full Text] [Related]
37. Effects of clopidogrel vs. prasugrel vs. ticagrelor on endothelial function, inflammatory parameters, and platelet function in patients with acute coronary syndrome undergoing coronary artery stenting: a randomized, blinded, parallel study. Schnorbus B; Daiber A; Jurk K; Warnke S; Koenig J; Lackner KJ; Münzel T; Gori T Eur Heart J; 2020 Sep; 41(33):3144-3152. PubMed ID: 31899473 [TBL] [Abstract][Full Text] [Related]
38. Novel oral P2Y12 inhibitor prasugrel vs. clopidogrel in patients with acute coronary syndrome: evidence based on 6 studies. Jia M; Li Z; Chu H; Li L; Chen K Med Sci Monit; 2015 Apr; 21():1131-7. PubMed ID: 25893318 [TBL] [Abstract][Full Text] [Related]
39. Trends in Platelet Adenosine Diphosphate P2Y12 Receptor Inhibitor Use and Adherence Among Antiplatelet-Naive Patients After Percutaneous Coronary Intervention, 2008-2016. Dayoub EJ; Seigerman M; Tuteja S; Kobayashi T; Kolansky DM; Giri J; Groeneveld PW JAMA Intern Med; 2018 Jul; 178(7):943-950. PubMed ID: 29799992 [TBL] [Abstract][Full Text] [Related]
40. Randomized Comparison of Oral P2Y Hochholzer W; Kleiner P; Younas I; Valina CM; Löffelhardt N; Amann M; Bömicke T; Ferenc M; Hauschke D; Trenk D; Neumann FJ; Stratz C JACC Cardiovasc Interv; 2017 Jan; 10(2):121-129. PubMed ID: 28104204 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]